Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 41

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus

Schneider, Miriam, de Vries, Petrus J., Schönig, Kai, Rößner, Veit, Waltereit, Robert · 2017 · European Archives of Psychiatry and Clinical Neuroscience

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00406-016-0703-8

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. Tuchman R, Rapin I (2002) Epilepsy in autism. Lancet Neurol 1:352–358 · DOI · Paper page
  2. Sato A, Kasai S, Kobayashi T et al (2012) Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun 3:1292. doi: 10.1038/ncomms2295 · DOI · Paper page
  3. Riikonen R, Amnell G (1981) Psychiatric disorders in children with earlier infantile spasms. Dev Med Child Neurol 23:747–760 · DOI · Paper page
  4. Primec ZR, Stare J, Neubauer D (2006) The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia 47:2202–2205 · DOI
  5. Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA (2005) Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 65:235–238 · DOI
  6. O’Callaghan FJ, Harris T, Joinson C et al (2004) The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 89:530–533 · DOI · Paper page
  7. Lynch M, Sayin U, Bownds J et al (2000) Long-term consequences of early postnatal seizures on hippocampal learning and plasticity. Eur J Neurosci 12:2252–2264 · DOI · Paper page
  8. Sayin U, Sutula TP, Stafstrom CE (2004) Seizures in the developing brain cause adverse long-term effects on spatial learning and anxiety. Epilepsia 45:1539–1548 · DOI
  9. Lim AL, Taylor DA, Malone DT (2012) Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research. Behav Brain Res 227:276–286. doi: 10.1016/j.bbr.2011.10.052 · DOI
  10. von der Brelie C, Waltereit R, Zhang L et al (2006) Impaired synaptic plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23:686–692. doi: 10.1111/j.1460-9568.2006.04594.x · DOI · Paper page
  11. Waltereit R, Welzl H, Dichgans J et al (2006) Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis. J Neurochem 96:407–413 · DOI · Paper page
  12. Waltereit R, Japs B, Schneider M et al (2011) Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behav Genet 41:364–372 · DOI · Paper page
  13. Kenerson HL, Aicher LD, True LD, Yeung RS (2002) Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 62:5645–5650
  14. Kenerson H, Dundon TA, Yeung RS (2005) Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 57:67–75. doi: 10.1203/01.PDR.0000147727.78571.07 · DOI · Paper page
  15. O’Reilly T, McSheehy PMJ, Kawai R et al (2009) Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents. Cancer Chemother Pharmacol 65:625–639 · DOI
  16. Rennebeck G, Kleymenova EV, Anderson R et al (1998) Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA 95:15629–15634 · DOI · Paper page
  17. Schneider M, Schomig E, Leweke FM (2008) Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict Biol 13:345–357 · DOI · Paper page
  18. Meikle L, Pollizzi K, Egnor A et al (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28:5422–5432. doi: 10.1523/JNEUROSCI.0955-08.2008 · DOI · Paper page
  19. Ishii R, Wataya-Kaneda M, Canuet L et al (2015) Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report. Neuropsychiatr Electrophysiol 1:6. doi: 10.1186/s40810-015-0004-x · DOI
  20. Chu-Shore CJ, Major P, Camposano S et al (2010) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51:1236–1241. doi: 10.1111/j.1528-1167.2009.02474.x · DOI · Paper page
  21. Deykin EY, MacMahon B (1979) The incidence of seizures among children with autistic symptoms. Am J Psychiatry 136:1310–1312 · DOI · Paper page
  22. Tuchman R, Cuccaro M (2011) Epilepsy and autism: neurodevelopmental perspective. Curr Neurol Neurosci Rep 11:428–434. doi: 10.1007/s11910-011-0195-x · DOI
  23. Smalley SL (1998) Autism and tuberous sclerosis. J Autism Dev Disord 28:407–414 · DOI · Paper page
  24. Gomez MR, Sampson JR, Whittemore VH (1999) The tuberous sclerosis complex. Oxford University Press, New York · DOI · Paper page
  25. de Vries PJ, Prather PA (2007) The tuberous sclerosis complex. N Engl J Med 356:92 · DOI · Paper page
  26. Zeng L-H, Xu L, Gutmann DH, Wong M (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444–453. doi: 10.1002/ana.21331 · DOI · Paper page
  27. Krueger DA, Wilfong AA, Holland-Bouley K et al (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74:679–687. doi: 10.1002/ana.23960 · DOI · Paper page
  28. Wong M (2013) A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev Neurother 13:657–669. doi: 10.1586/ern.13.48 · DOI
  29. de Vries PJ, Howe CJ (2007) The tuberous sclerosis complex proteins—a GRIPP on cognition and neurodevelopment. Trends Mol Med 13:319–326 · DOI · Paper page
  30. Napolioni V, Moavero R, Curatolo P (2009) Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev 31:104–113. doi: 10.1016/j.braindev.2008.09.013 · DOI

Cited by

See all 41

Metadata

Authors
Schneider, M., de Vries, P. J., Schönig, K., Rößner, V., & Waltereit, R.
Venue
European Archives of Psychiatry and Clinical Neuroscience
Published
2016-06-04
Volume
267
Issue
5
Pages
455-463
ISSN
  • 0940-1334
  • 1433-8491
Cited by
41
References
9
Language
en
Funders
Novartis Germany (SVOT-004)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.